Treatment with suramin resulted in a marked decrease in TNF-α levels (40.1 ± 1.9 pg/mL), demonstrating significant attenuation of inflammatory response compared to colitis group (# p < 0.01), (Figure 2 and Table 1). Here, TNF is linked to colitis.